Fuzheng Huayu formula ameliorates chronic cholestatic liver injury by upregulating PPARa in mice
{{output}}
Background: Fuzheng Huayu formula (FZHY) has been extensively applied in clinical for liver fibrosis treatment in China, its therapeutic potential in cholestatic liver injury remains underexplored. ... ...